Please Wait...

Regulatory Leadership

Trusted Regulatory Expertise

Engage Bioclinica early in your drug development program to leverage an exceptional level of regulatory, scientific and operational expertise. For more than 30 years, Bioclinica has accelerated drug development research, working in tandem with regulatory bodies and key clinical research associations to establish core lab industry standards.

Bioclinica's unmatched scientific and regulatory leadership is well recognized and backed by ongoing professional relationships with key authorities and panels. We have an unprecedented number of successful, medical image data submissions on many high-profile drugs on the market today.

Years of Experience
FDA approvals

Leverage Bioclinica's Expertise

Contact us for more information or to speak with us about how we can support your next trial.


Streamlined Regulatory Process

Our experts have a deep understanding of imaging review charter and protocol development, adhering to guidance and directives from the FDA, EMA, and other regulatory agencies. Bioclinica senior team members participate in FDA meetings and workshops, taking an active leadership role in shaping new guidance surrounding imaging endpoints in clinical trials. Our significant experience in charter and protocol development means effective trial conduct and preparedness for regulatory review. Bioclinica ensures complete image data archival and all processes are in full compliance with 21 CFR Part 11.

Therapeutic Strength

Bioclinica offers extensive international experience including working in tandem with a wide array of organizations, across most major indications, in more than 70 countries. Working alongside global regulatory authorities, Bioclinica lead the advancement of Thorough QT (TQT) and Intensive QT trial design, highlighted by the completion of the first-ever TQT studies in China and Japan.

Learn More

Oncology Superiority

Bioclinica is proud to have contributed to 70+ FDA approvals for treating a wide variety of oncology indications. Our extensive medical experience, coupled with our commitment to quality, enables us to support every type of oncology trial.


The association of many oncology drugs with cardiotoxic side effects necessitates independent cardiac safety studies for therapies in development. Bioclinica has extensive expertise in planning and implementing cardiac safety studies (ICH-E14 mandated Thorough QT services, blood pressure analysis, etc), facilitating the assessment of drugs early in clinical development.




Seeking Clarity in the Audit Approach

Read Blog

On Demand Webinar - Critical Regulatory Considerations for Imaging Trials: What You Need to Know

Watch On Demand Webinar

Medical Imaging Services for Clinical Trials

Download Brochure

Oncology Imaging Expertise


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Join @bioclinica's Research Dev. Dir. Marieke Cajal, PhD @adpdnet 3/18 where she will speak on patient engagement…
bioclinica (19 hours ago)
Still on the fence about #eSource? Here R some key considerations & inside tips for successful implementation & how…
bioclinica (23 hours ago)
Almost here! #ASCPT2018 Tour central Florida's premier Phase 1 facility at our Open House 3/22! Meet our team & see…
bioclinica (Yesterday)
RT @FDAWomen: Today we welcomed minority health stakeholders during FDA’s first Minority Health Listening Session. Thank you for this discu…
bioclinica (Yesterday)
RT @melfass: The House has rejected the "Right to Try" bill, opponents of which said would have compromised the #clinicaltrials process. cc…
bioclinica (Yesterday)
RT @eClinical_Jen: Here what the FDA has to say on using Microsoft Excel for Clinical Trial data: #eHealth #Pharm…
bioclinica (Yesterday)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen